Revisiting biomarker discovery by plasma proteomics

Philipp E Geyer, Lesca M Holdt, Daniel Teupser, Matthias Mann

    227 Citationer (Scopus)
    86 Downloads (Pure)

    Abstract

    Clinical analysis of blood is the most widespread diagnostic procedure in medicine, and blood biomarkers are used to categorize patients and to support treatment decisions. However, existing biomarkers are far from comprehensive and often lack specificity and new ones are being developed at a very slow rate. As described in this review, mass spectrometry (MS)-based proteomics has become a powerful technology in biological research and it is now poised to allow the characterization of the plasma proteome in great depth. Previous "triangular strategies" aimed at discovering single biomarker candidates in small cohorts, followed by classical immunoassays in much larger validation cohorts. We propose a "rectangular" plasma proteome profiling strategy, in which the proteome patterns of large cohorts are correlated with their phenotypes in health and disease. Translating such concepts into clinical practice will require restructuring several aspects of diagnostic decision-making, and we discuss some first steps in this direction.

    OriginalsprogEngelsk
    Artikelnummer942
    TidsskriftMolecular Systems Biology
    Vol/bind13
    Udgave nummer9
    Antal sider16
    ISSN1744-4292
    DOI
    StatusUdgivet - 26 sep. 2017

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Revisiting biomarker discovery by plasma proteomics'. Sammen danner de et unikt fingeraftryk.

    Citationsformater